- Risk of Severe COVID-19 Infection and Other SARIs in Preexisting … – Physician’s Weekly:Researchers conducted a study to explore the relationship between preexisting neuropsychiatric disorders and severe outcomes from COVID-19 infection and other SARIs.
- COVID-19 Cases Decline, County Urges People to Get Vaccinated, Boosted – countynewscenter.com: San Diego County health officials continue to urge people to get the primary COVID–19 vaccine series and the bivalent boosters. The vaccines protect against serious illness, hospitalization, and death, and help protect against new variants. Vaccines and treatments are widely available throughout San Diego County.
- News at a glance: Pandemic declarations, job satisfaction in the … – Science: WHO declared this week that the COVID–19 pandemic continues to be a Public Health Emergency of International Concern (PHEIC). The special emergency committee for the disease suggested that the designation might end later this year, but noted that the disease remains dangerous. The US administration of President Joe Biden said it will end the US declaration of a national public health emergency in May, which has paid for COVID–19 testing and treatment for those without insurance.
- What are the existing support models for caregivers and patients with long COVID? – News-Medical.Net:Long COVID is a condition that affects individuals who have had prior COVID-19, with lasting symptoms for at least two months. It can cause functional disability, requiring home care and support to improve quality of life.
- The 7 symptoms MU researchers connected with long COVID using … – Columbia Daily Tribune: Researchers at the University of Missouri have identified seven long COVID symptoms that can linger for months or years after the virus has left the body: rapid heartbeat, hair loss, fatigue, chest pain, shortness of breath, joint pain, and obesity.
- IL-6 receptor antagonists, antiplatelets show high probability of … – Healio: Interleukin–6 receptor antagonists and antiplatelet agents were found to improve the 6–month survival rate among critically ill patients with COVID–19, according to a study presented at the Society of Critical Care Medicine‘s Critical Care Congress and published in JAMA. Lead researcher Lisa Higgins noted that the benefits of the treatment persisted after 6 months in the form of improved long–term survival and quality of life.
- ASBMB calls for broad federal effort to support scientists with … – ASBMB Today: The American Society for Biochemistry and Molecular Biology endorsed the National Institutes of Health’s recent report on actions to support disabled scientists. The society urged the NIH to implement the report‘s recommendations, incorporate anti–ableism into diversity initiatives, and establish funding opportunities for disability research. They also emphasized that the NIH‘s mission statement be updated to eliminate ableist language.
- Accessibility at Mac or Lack Thereof – Macalester College The Mac Weekly: Colleges must pay more attention to disability studies, justice, and accessibility for all to address the increasing number of disabled students in light of the COVID–19 pandemic.
- Low immunity, overwhelmed hospitals fuel Covid-19 deaths in ageing Japan – BBC: Japan, which once had one of the lowest Covid mortality rates, is seeing a surge in coronavirus deaths due to the population‘s low immunity against Covid–19 and a growing population of frail elderly. This is compounded by the emergence of variants that are capable of evading the human host‘s immune system, making it difficult to prevent infections and deaths.
- Japan is seeing a record number of COVID-19 deaths. What’s behind this surge? – Firstpost: Japan has seen an increase in COVID–19 deaths in the last few months of 2022, with January 2021 recording 10,124 fatalities. This is due to a combination of factors, including an increase in the number of infections, a decrease in compliance with preventive measures, and the downgrading of medical classification for the virus.
- How quickly does COVID immunity fade? What scientists know – Nature.com: Evidence suggests that hybrid immunity, resulting from both vaccination and infection, can provide partial protection against reinfection for at least eight months and 95% protection against severe disease or hospitalization for up to a year. However, the durability of immunity varies depending on how well immune cells recognize their target, which may be affected by virus mutation.
Daily News Pulse for March 13, 2023
Summary: Princeton students have seen an overall improvement in course satisfaction since the start of the COVID-19 pandemic. In Japan, many people are still wearing masks despite the government’s easing of guidelines.
